Gestalt Spent Eight Years Building the Boring Layer of Pathology - Now AI Has Somewhere Useful to Work

Most pathology AI companies sell the clever answer. Gestalt sells the place where the slide, the case, the pathologist and competing algorithms can finally meet - a workflow-first bet backed by a $7.5 million Series A.